BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37002535)

  • 1. Double mutation of claudin-1 and claudin-3 causes alopecia in infant mice.
    Suzuki K; Yamaga K; Tokumasu R; Katsuno T; Tanaka H; Chiba S; Yagi T; Katayama I; Tamura A; Murota H; Tsukita S
    Ann N Y Acad Sci; 2023 May; 1523(1):51-61. PubMed ID: 37002535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin expression in breast cancer: high or low, what to expect?
    Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
    Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse.
    Blanchard AA; Watson PH; Shiu RP; Leygue E; Nistor A; Wong P; Myal Y
    DNA Cell Biol; 2006 Feb; 25(2):79-86. PubMed ID: 16460231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
    Lin X; Shang X; Manorek G; Howell SB
    PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
    Zhou S; Piao X; Wang C; Wang R; Song Z
    Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polar and charged extracellular residues conserved among barrier-forming claudins contribute to tight junction strand formation.
    Piontek A; Rossa J; Protze J; Wolburg H; Hempel C; Günzel D; Krause G; Piontek J
    Ann N Y Acad Sci; 2017 Jun; 1397(1):143-156. PubMed ID: 28415153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
    Shang X; Lin X; Alvarez E; Manorek G; Howell SB
    Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight Junction barriers in human hair follicles - role of claudin-1.
    Zorn-Kruppa M; Vidal-Y-Sy S; Houdek P; Wladykowski E; Grzybowski S; Gruber R; Gorzelanny C; Harcup J; Schneider SW; Majumdar A; Brandner JM
    Sci Rep; 2018 Aug; 8(1):12800. PubMed ID: 30143655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
    Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudins and hepatocellular carcinoma.
    Wang W; Zhou Y; Li W; Quan C; Li Y
    Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
    Uthayanan L; El-Bahrawy M
    J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
    Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
    Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
    Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
    PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-3, claudin-7, and claudin-10 show different distribution patterns during decidualization and trophoblast invasion in mouse and human.
    Schumann S; Buck VU; Classen-Linke I; Wennemuth G; Grümmer R
    Histochem Cell Biol; 2015 Dec; 144(6):571-85. PubMed ID: 26340953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting.
    Yang H; Park H; Lee YJ; Choi JY; Kim T; Rajasekaran N; Lee S; Song K; Hong S; Choi JS; Shim H; Kim YD; Hwang S; Choi YL; Shin YK
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
    Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
    Front Genet; 2022; 13():783016. PubMed ID: 35281827
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis.
    Arabzadeh A; Troy TC; Turksen K
    BMC Cancer; 2007 Oct; 7():196. PubMed ID: 17945025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.